home · filing · 0001437749-21-022445
8-K filed September 21, 2021, 7:59 PM ET
ticker NAII
CIK 0000787253
earnings
confidence high
sentiment positive
materiality 0.85
NAI reports record FY2021 sales $178.5M, net income $10.8M; guides FY2022 sales up 5-10%
NATURAL ALTERNATIVES INTERNATIONAL INC
Q4 net sales $44.4M (+26.5% YoY); diluted EPS $0.47 vs $0.27 prior year.
FY2021 net sales $178.5M (+50.2%); net income $10.8M vs net loss $1.6M in FY2020.
CarnoSyn royalty revenue up 102.6% in Q4; private-label manufacturing sales +54.6% for year.
FY2022 guidance: net sales +5-10% YoY; operating income 7-9% of sales; first half slower due to supply chain.
Appoints Dr. Guru Ramanathan (former GNC Chief Innovation Officer) as independent director.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2021-09-17
Filed September 21, 2021, 7:59 PM ET
The Board appointed Dr. Guru Ramanathan to complete the remaining term of the deceased director.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Dr. Guru Ramanathan was appointed as Director at NATURAL ALTERNATIVES INTERNATIONAL INC.
Action appointed
Role Director
Exact text from the filing
The Board appointed Dr. Guru Ramanathan to complete the remaining term of the deceased director.
View on SEC.gov
Source: SEC EDGAR
accession 0001437749-21-022445
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.